Andrea L. Murphy

Associate Professor


Mailing Address: 
5968 College Street
PO Box 15000
College of Pharmacy
Dalhousie University
Halifax, NS
B3H 4R2
Research Topics:
  • Mental health; Substance use disorders; Suicide
  • Pharmacoepidemiology
  • Models of care
  • Knowledge translation and implementation science
  • Pharmacy practice


  • BSc(Pharm) (Dalhousie)
  • PharmD (UBC)
  • ACPR
  • Fellowship, Drug Use Management and Policy  

Research interests

My program of research is focused on health services and health outcomes. I work with multidisciplinary teams exploring the impact of interventions on health care quality and its dimensions (e.g., safety, acceptability, accessibility).  As an implementation scientist, my research includes the design, development, implementation, and evaluation of interventions alongside translating research products for stakeholders ranging from members of the public to politicians.

Selected publications

  • Murphy, A.L., Turner, J.P., Rajda, M., Allen, K.G., Pinter, K., Gardner, D.M. (2023).  Effectiveness and cost analysis of methods used to recruit older adult sedative users to a deprescribing randomized controlled trial during the COVID-19 pandemic.  Exploratory Research in Clinical and Social Pharmacy. 8, 100214. DOI: 10.1016/j.rcsop.2002.100214.
  • Murphy, A.L., O’Reilly, C.L., Ataya, R., Doucette, S., Burge, F., Salvadore Carulla, L.,Rosen, A., Chen, T., Himmelman, D., Kutcher, S.P., Marin-Misener, R., Rosen, A., Gardner, D.M. (2020). A survey of Australian and Canadian community pharmacists’ experiences with people at risk of suicide. Psychiatric Services. 71(2), 293-296. DOI: 10.1176/
  • Haslam, L., Gardner, D.M., Murphy, A.L. (2020). A retrospective analysis of patient care activities in a community pharmacy mental illness and addictions program. Research in Social and Administrative Pharmacy. 16(4), 522-528. DOI: 10.1016/j.sapharm.2019.07.003
  • Shaw, J., Murphy, A.L., Gardner, D.M., Turner, J., Bouck, Z., Gordon, D., Silvius, J., Tannenbaum, C. (2019). Policies for deprescribing: an international scan of intended and unintended outcomes of policy aiming to limit sedative-hypnotic use in community-dwelling older adults. Healthcare Policy. 14(4), 39-51.
  • Barker, J.R., Boyle, T.A., Tay, L., Bishop, A., Morrison, B., Murphy, A., MacKinnon, N.J., Murray, E., Ho, C. (2019). Barriers to the use of patient safety information sources by community pharmacies. Research in Social and Administrative Pharmacy. 15(7), 895-901. DOI: 10.1016/j.sapharm.2019.02.015